Literature DB >> 9542519

Endothelin-1 and tumour development.

E H Asham1, M Loizidou, I Taylor.   

Abstract

There has been a growing conviction amongst oncologists that cancer is a disease characterized by changes in specific molecules. These changes include alteration in the structure, regulation or quantity of growth factors and their receptors, signal transducers and the proteins encoded by dominant or suppressor/recessive oncogenes. The role of endothelin (vasoactive peptide) in tumour cell signal transduction and mitogenesis and induction of endothelial cell growth and angiogenesis in tumour growth is discussed in this article.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9542519     DOI: 10.1016/s0748-7983(98)80128-5

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  4 in total

1.  Functional interactions between tumor and peripheral nerve: morphology, algogen identification, and behavioral characterization of a new murine model of cancer pain.

Authors:  P W Wacnik; L J Eikmeier; T R Ruggles; M L Ramnaraine; B K Walcheck; A J Beitz; G L Wilcox
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

2.  Selective inhibition of endothelin receptor A as an anti-angiogenic and anti-proliferative strategy for human pancreatic cancer.

Authors:  Sarah Bhargava; Till Stummeyer; Birgit Hotz; O Joe Hines; Howard A Reber; Heinz J Buhr; Hubert G Hotz
Journal:  J Gastrointest Surg       Date:  2005 May-Jun       Impact factor: 3.452

3.  The endothelin system in Morris hepatoma-7777: an endothelin receptor antagonist inhibits growth in vitro and in vivo.

Authors:  Thiemo Pfab; Gisela Stoltenburg-Didinger; Christoph Trautner; Michael Godes; Christian Bauer; Berthold Hocher
Journal:  Br J Pharmacol       Date:  2003-12-08       Impact factor: 8.739

4.  Serum big endothelin-1 as a biomarker in oral squamous cell carcinoma patients: an analytical study.

Authors:  Pritam Kumar Mankapure; Suresh Ramchandra Barpande; Jyoti Dilip Bhavthankar; Manda Mandale
Journal:  J Appl Oral Sci       Date:  2015-10       Impact factor: 2.698

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.